Joseph Comaty, Adjunct Assistant Professor

Office: 236 Audubon Hall
Department of Psychology
Louisiana State University
Baton Rouge, LA 70808
Phone: 225-922-3243

Present Positions

Chief Psychologist
HIPAA Privacy Officer
Chief - Bureau of Applied Research and Program Evaluation
Division of Planning, Evaluation, and Information Technology
Louisiana Office of Mental Health
Department of Health and Hospitals
1885 Wooddale Blvd., Room 925
Baton Rouge, LA 70806
Phone: 225-922-3243
Fax: 225-925-4790

Adjunct Assistant Professor
Department of Psychology
Louisiana State University
236 Audubon Hall
Baton Rouge, LA 70803

Adjunct Faculty
Post-Doctoral Master’s Degree Program in Clinical Psychopharmacology
CSPP/Alliant International University
One Beach St., Suite 100
San Francisco, CA 94133

Research Interests

My primary area of research is clinical psychopharmacology. In particular, I am interested in the study of the clinical treatment for the major psychiatric disorders of schizophrenia, major depression, and bipolar disorder. I have experience conducting clinical trials of new medications for the treatment of psychiatric disorders and more recently, in collaboration with Dr. Claire Advokat of this department, have been conducting ‘naturalistic’ or ‘real world’ studies examining the effectiveness of the newer antipsychotic medications.

The requirements for bringing a drug to market involve the use of controlled clinical trials that use very homogenous patient groups who do not have any other disorders than the one for which the drug is intended. When these drugs are approved and used more broadly in general psychiatric patient populations who have multiple disorders (such as mental illness and substance abuse), they appear to demonstrate less effectiveness than predicted by results from controlled clinical trials. Therefore, it is important to examine how effective these drugs are when being used for a broad range of psychiatric conditions and for individuals who may have more than one clinical disorder.

Clinical Interests

Clinical Psychopharmacology
Diagnostic Assessment / Mental Status Examination
Use of Clinical Rating Scales
Functional Analysis / Behavior Therapy
Program Development / Program Evaluation

Licenses and Certifications

Louisiana Certificate of Prescription #682MP (Medical Psychologist)
Current State CDS and Federal DEA licenses
Louisiana License to Practice Psychology #682


Post-doctoral Masters of Science in Clinical Psychopharmacology
CSPP/Alliant International University
San Francisco, California

Ph.D., Clinical Psychology
Rosalind Franklin University of Medicine and Science
North Chicago, IL 60064

M.S., Experimental Psychology
Villanova University
Villanova, PA 19085

A.B., Psychology
Villanova University
Villanova, PA 19085

Representative Publications

Advokat, C.D., L.J. Bertman, J.E. Comaty. Clinical outcome to clozapine treatment in chronic psychiatric inpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 23: 1-14, 1999.

Vesce, J., J.E. Comaty, C. Advokat. Antiaggressive action of atypical antipsychotics in patients with schizophrenia. Journal of Clinical Psychopharmacology, 21, 353-355, 2001 (Letter).

Comaty, J.E. and C. Advokat. Indications for the use of atypical antipsychotics in the elderly. Journal of Clinical Geropsychology, 7, 285-308, 2001.

Comaty, J.E., Stasio, M., Advokat, C. Analysis of outcome variables of a token economy (TE) treatment program in a state psychiatric hospital. Research in Developmental Disabilities, 22: 233-253, 2001.

Advokat, C., Dixon, D., Schneider, J., Comaty, J.E. Comparison of risperidone and olanzapine as used under ‘real-world’ conditions in a state psychiatric hospital, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28: 487-495, 2004.

Advokat, C.D. and Comaty, J.E. Pharmacoeconomics of second-generation antipsychotics, Contemporary Psychiatry, 3: 1-10, 2004.